12th Annual Update on Vascular Disease

This live in-person course covers topics in vascular medicine, surgical and endovascular treatments, including diagnostic testing, clinical guidelines, and the latest research and discoveries. Learn more about potential benefits and risks of various therapies, and how they might impact patient care. Concurrent sessions will focus on vascular laboratory testing and team-based management of pulmonary embolism. Opportunities for multi-specialty collaboration are emphasized.

Friday, April 14, 2023, 8:30 AM - Saturday, April 15, 2023, 5:15 PM, Hilton Cleveland Downtown, Cleveland, OH

1. Apply current diagnostic and therapeutic strategies for arterial, venous, and aortic disease
2. Review recent advances in medical, endovascular, and surgical therapies for vascular disorders
3. Recognize the importance multispecialty care in the care of patients with vascular disease
4. Identify strategies to optimize imaging and interpretation of non-invasive studies for common and uncommon vascular disorders
5. Identify strategies for risk stratification and treatment of pulmonary embolism across the spectrum of disease severity

Physician - Day 1  - $100
Physician - Day 2 - $100
Physician - both days - $175

Trainee/nurse/tech - Day 1 - $50
Trainee/nurse/tech - Day 2 - $50
Trainee/nurse/tech - both days - $75

Case Western Reserve University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

AMA PRA Category 1 Credits™ (11.00 hours), Non-Physician Attendance (11.00 hours)

Mitigation of Relevant Financial Relationships

CWRU School of Medicine adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.